MEDWELLAI, INC.

MWAI

CIK 0001520118 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$548K
↑+283.8% +$405Kvs FY2024 (Q4)
Operating Income
$526K
↑+340.6% +$407Kvs FY2024 (Q4)
Gross Profit
$548K
↑+283.8% +$405Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
67/100
  • Profitability
    100ROIC 42.8% (10% = solid, 20%+ = moat)
  • Liquidity
    0Current Ratio 0.14 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    4Asset Turnover 0.25x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +283.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -50.0% · trend +16920.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$0
investment in PP&E
Dividends paid (TTM)
cash returned to holders
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$650K
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$461K
everything owned
Total liabilities
$8M
everything owed
Stockholders' equity
$-7M
shareholder claim
Net debt
$270K
LT debt minus cash

Recent performance · 59 quarters

Revenue↑+283.8% +$405K
$548K
Net Income↑+57.3% +$386K
$-288K
Free Cash Flow↑+30.9% +$76K
$-171K
Operating Margin↑+170.6pts
-50.0%

Drill down